Catechins for the treatment of amyloidosis
OwnerJoel Cummings, Alan D. Snowinventors
Life of this patent
Estimating the term…
Abstract
A method of treating an amyloid disease characterized by AL amyloid fibrillogenesis, in a mammalian subject. The method includes administering to the mammal a therapeutically effective amount of a various disclosed catechins. The therapeutic amount of the catechin is selected for efficacy in treating AL amyloid fibrillogenesis in a mammalian subject.
Claims4
A method of treating a disease characterized by AL amyloid deposition, in a mammalian subject, the method comprising administering to a mammal a therapeutically effective amount of a compound selected from the group consisting of epicatechin, epigallocatechin gallate, epigallocatechin, and epicatechin gallate, and pharmaceutically acceptable salts thereof.
A method of inhibiting AL amyloid deposition in a mammalian subject, the method comprising administering to the mammal a therapeutically effective amount of a compound selected from the group consisting of;
- epicatechin, epigallocatechin gallate, epigallocatechin, and epicatechin gallate, and pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.